OTC Healthcare in Western Europe to 2013

Introduction

This databook provides key data and information on the OTC healthcare market covering 17 countries in Western Europe. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.

Scope

*Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits

*Market, category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data

*Category level company and brand share as well as distribution share information for 2007 and 2008

*Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description

Highlights

The market for OTC healthcare in Western Europe increased at a compound annual growth rate of 2.4% between 2003 and 2008.

The cough and cold preparations category led the OTC healthcare market in Western Europe, accounting for a share of 18.2%.

The leading players in the Western European OTC healthcare market include Johnson & Johnson, Bayer AG and GlaxoSmithKline Plc.

Reasons to Purchase

*Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Western Europe

*Design effective marketing and sales strategies by identifying key market categories and segments

*Identify key players within the market to plan lucrative M&A, partnerships and agreements


Report Highlights

[Studien Infos ausblenden]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary market level: OTC healthcare 2
Summary category level: analgesics 3
Summary category level: topical OTC medicines 4
Summary category level: cough and cold preparations 5
Summary category level: indigestion preparations 6
Summary category level: medicated skin products 7
Summary category level: first aid kits 8
Summary category level: other OTC healthcare products 9
Summary category level: plasters & bandages 10
Summary category level: traditional medicines 11
Summary category level: vitamins and minerals 12
Chapter 2 Introduction 13
What is this report about? 13
How to use this report 13
Market definition 14
Chapter 3 OVERVIEW 28
Value Analysis 28
Chapter 4 Western Europe OTC Healthcare - Market Overview 30
Value analysis (US dollar), 2003?08 30
Value analysis (US dollar), 2008?13 32
Company share analysis 35
Distribution analysis 38
Chapter 5 Leading Company Profiles 40
Johnson & Johnson 40
Bayer AG 42
Chapter 6 Category Analysis: Analgesics 45
Value analysis (US dollar), 2003?08 45
Value analysis (US dollar), 2008?13 46
Company share analysis 48
Distribution analysis 51
Chapter 7 Category Analysis: Topical OTC Medicines 53
Value analysis (US dollar), 2003?08 53
Value analysis (US dollar), 2008?13 54
Company share analysis 56
Distribution analysis 59
Chapter 8 Category Analysis: Cough and Cold Preparations 61
Value analysis (US dollar), 2003?08 61
Value analysis (US dollar), 2008?13 62
Company share analysis 64
Distribution analysis 67
Chapter 9 Category Analysis: Indigestion Preparations 69
Value analysis (US dollar), 2003?08 69
Value analysis (US dollar), 2008?13 70
Company share analysis 72
Distribution analysis 75
Chapter 10 Category Analysis: Medicated Skin Products 77
Value analysis (US dollar), 2003?08 77
Value analysis (US dollar), 2008?13 78
Company share analysis 80
Distribution analysis 83
Chapter 11 Category Analysis: First Aid Kits 85
Value analysis (US dollar), 2003?08 85
Value analysis (US dollar), 2008?13 86
Company share analysis 87
Distribution analysis 90
Chapter 12 Category Analysis: Other OTC Healthcare Products 92
Value analysis (US dollar), 2003?08 92
Value analysis (US dollar), 2008?13 93
Company share analysis 95
Distribution analysis 98
Chapter 13 Category Analysis: Plasters & Bandages 100
Value analysis (US dollar), 2003?08 100
Value analysis (US dollar), 2008?13 101
Company share analysis 103
Distribution analysis 106
Chapter 14 Category Analysis: Traditional Medicines 108
Value analysis (US dollar), 2003?08 108
Value analysis (US dollar), 2008?13 109
Company share analysis 110
Distribution analysis 113
Chapter 15 Category Analysis: Vitamins and Minerals 115
Value analysis (US dollar), 2003?08 115
Value analysis (US dollar), 2008?13 116
Company share analysis 118
Distribution analysis 121
Chapter 16 Research Methodology 123
Methodology overview 123
Secondary research 124
Market modeling 125
Creating an initial data model 125
Revising the initial data model 125
Creating a final estimate 126
Creating demographic value splits 126
Primary research 126
Data finalization 127
Ongoing research 127
Chapter 17 APPENDIX 128
Future readings 128
How to contact experts in your industry 128
Disclaimer 128

LIST OF FIGURES
Figure 1: Western Europe OTC healthcare value and value forecast, 2003?13 ($m, nominal prices) 33
Figure 2: Western Europe OTC healthcare category growth comparison, by value, 2003?13 34
Figure 3: Western Europe OTC healthcare company share (top five companies), by value, 2007?08 (%) 37
Figure 4: Western Europe OTC healthcare distribution channels, by value, 2007?08 (%) 39
Figure 5: Western Europe analgesics value and value forecast, 2003?13 ($m, nominal prices) 47
Figure 6: Western Europe analgesics category growth comparison, by value, 2003?13 47
Figure 7: Western Europe analgesics company share (top five companies), by value, 2007?08 (%) 50
Figure 8: Western Europe analgesics distribution channels, by value, 2007?08 (%) 52
Figure 9: Western Europe topical OTC medicines value and value forecast, 2003?13 ($m, nominal prices) 55
Figure 10: Western Europe topical OTC medicines category growth comparison, by value, 2003?13 55
Figure 11: Western Europe topical OTC medicines company share (top five companies), by value, 2007?08 (%) 58
Figure 12: Western Europe topical OTC medicines distribution channels, by value, 2007?08 (%) 60
Figure 13: Western Europe cough and cold preparations value and value forecast, 2003?13 ($m, nominal prices) 63
Figure 14: Western Europe cough and cold preparations category growth comparison, by value, 2003?13 63
Figure 15: Western Europe cough and cold preparations company share (top five companies), by value, 2007?08 (%) 66
Figure 16: Western Europe cough and cold preparations distribution channels, by value, 2007?08 (%) 68
Figure 17: Western Europe indigestion preparations value and value forecast, 2003?13 ($m, nominal prices) 71
Figure 18: Western Europe indigestion preparations category growth comparison, by value, 2003?13 71
Figure 19: Western Europe indigestion preparations company share (top five companies), by value, 2007?08 (%) 74
Figure 20: Western Europe indigestion preparations distribution channels, by value, 2007?08 (%) 76
Figure 21: Western Europe medicated skin products value and value forecast, 2003?13 ($m, nominal prices) 79
Figure 22: Western Europe medicated skin products category growth comparison, by value, 2003?13 79
Figure 23: Western Europe medicated skin products company share (top five companies), by value, 2007?08 (%) 82
Figure 24: Western Europe medicated skin products distribution channels, by value, 2007?08 (%) 84
Figure 25: Western Europe first aid kits value and value forecast, 2003?13 ($m, nominal prices) 86
Figure 26: Western Europe first aid kits company share (top five companies), by value, 2007?08 (%) 89
Figure 27: Western Europe first aid kits distribution channels, by value, 2007?08 (%) 91
Figure 28: Western Europe other OTC healthcare products value and value forecast, 2003?13 ($m, nominal prices) 94
Figure 29: Western Europe other OTC healthcare products category growth comparison, by value, 2003?13 94
Figure 30: Western Europe other OTC healthcare products company share (top five companies), by value, 2007?08 (%) 97
Figure 31: Western Europe other OTC healthcare products distribution channels, by value, 2007?08 (%) 99
Figure 32: Western Europe plasters & bandages value and value forecast, 2003?13 ($m, nominal prices) 102
Figure 33: Western Europe plasters & bandages category growth comparison, by value, 2003?13 102
Figure 34: Western Europe plasters & bandages company share (top five companies), by value, 2007?08 (%) 105
Figure 35: Western Europe plasters & bandages distribution channels, by value, 2007?08 (%) 107
Figure 36: Western Europe traditional medicines value and value forecast, 2003?13 ($m, nominal prices) 109
Figure 37: Western Europe traditional medicines company share (top five companies), by value, 2007?08 (%) 112
Figure 38: Western Europe traditional medicines distribution channels, by value, 2007?08 (%) 114
Figure 39: Western Europe vitamins and minerals value and value forecast, 2003?13 ($m, nominal prices) 117
Figure 40: Western Europe vitamins and minerals category growth comparison, by value, 2003?13 117
Figure 41: Western Europe vitamins and minerals company share (top five companies), by value, 2007?08 (%) 120
Figure 42: Western Europe vitamins and minerals distribution channels, by value, 2007?08 (%) 122
Figure 43: Annual data review process 124

LIST OF TABLES
Table 1: OTC healthcare category definitions 15
Table 2: OTC healthcare distribution channels 17
Table 3: Western Europe OTC healthcare value (country-wise), 2003?08 ($m, nominal prices) 28
Table 4: Western Europe OTC healthcare value (country-wise) forecast, 2008?13 ($m, nominal prices) 29
Table 5: Western Europe OTC healthcare value, 2003?08 ($m, nominal prices) 31
Table 6: Western Europe OTC healthcare value forecast, 2008?13 ($m, nominal prices) 32
Table 7: Western Europe OTC healthcare company share (top 20 companies) by value, 2007?08 (%) 35
Table 8: Western Europe OTC healthcare value, by company, 2007?08 ($m, nominal prices) 36
Table 9: Western Europe OTC healthcare distribution channels, by value, 2007?08 (%) 38
Table 10: Western Europe OTC healthcare value, by distribution channel, 2007?08 ($m, nominal prices) 38
Table 11: Johnson & Johnson key facts 40
Table 12: Bayer AG key facts 42
Table 13: Western Europe analgesics value, 2003?08 ($m, nominal prices) 45
Table 14: Western Europe analgesics value forecast, 2008?13 ($m, nominal prices) 46
Table 15: Western Europe analgesics company share (top 20 companies) by value, 2007?08 (%) 48
Table 16: Western Europe analgesics value, by company, 2007?08 ($m, nominal prices) 49
Table 17: Western Europe analgesics distribution channels, by value, 2007?08 (%) 51
Table 18: Western Europe analgesics value, by distribution channel, 2007?08 ($m, nominal prices) 51
Table 19: Western Europe topical OTC medicines value, 2003?08 ($m, nominal prices) 53
Table 20: Western Europe topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 54
Table 21: Western Europe topical OTC medicines company share (top 20 companies) by value, 2007?08 (%) 56
Table 22: Western Europe topical OTC medicines value, by company, 2007?08 ($m, nominal prices) 57
Table 23: Western Europe topical OTC medicines distribution channels, by value, 2007?08 (%) 59
Table 24: Western Europe topical OTC medicines value, by distribution channel, 2007?08 ($m, nominal prices) 59
Table 25: Western Europe cough and cold preparations value, 2003?08 ($m, nominal prices) 61
Table 26: Western Europe cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 62
Table 27: Western Europe cough and cold preparations company share (top 20 companies) by value, 2007?08 (%) 64
Table 28: Western Europe cough and cold preparations value, by company, 2007?08 ($m, nominal prices) 65
Table 29: Western Europe cough and cold preparations distribution channels, by value, 2007?08 (%) 67
Table 30: Western Europe cough and cold preparations value, by distribution channel, 2007?08 ($m, nominal prices) 67
Table 31: Western Europe indigestion preparations value, 2003?08 ($m, nominal prices) 69
Table 32: Western Europe indigestion preparations value forecast, 2008?13 ($m, nominal prices) 70
Table 33: Western Europe indigestion preparations company share (top 20 companies) by value, 2007?08 (%) 72
Table 34: Western Europe indigestion preparations value, by company, 2007?08 ($m, nominal prices) 73
Table 35: Western Europe indigestion preparations distribution channels, by value, 2007?08 (%) 75
Table 36: Western Europe indigestion preparations value, by distribution channel, 2007?08 ($m, nominal prices) 75
Table 37: Western Europe medicated skin products value, 2003?08 ($m, nominal prices) 77
Table 38: Western Europe medicated skin products value forecast, 2008?13 ($m, nominal prices) 78
Table 39: Western Europe medicated skin products company share (top 20 companies) by value, 2007?08 (%) 80
Table 40: Western Europe medicated skin products value, by company, 2007?08 ($m, nominal prices) 81
Table 41: Western Europe medicated skin products distribution channels, by value, 2007?08 (%) 83
Table 42: Western Europe medicated skin products value, by distribution channel, 2007?08 ($m, nominal prices) 83
Table 43: Western Europe first aid kits value, 2003?08 ($m, nominal prices) 85
Table 44: Western Europe first aid kits value forecast, 2008?13 ($m, nominal prices) 86
Table 45: Western Europe first aid kits company share (top 20 companies) by value, 2007?08 (%) 87
Table 46: Western Europe first aid kits value, by company, 2007?08 ($m, nominal prices) 88
Table 47: Western Europe first aid kits distribution channels, by value, 2007?08 (%) 90
Table 48: Western Europe first aid kits value, by distribution channel, 2007?08 ($m, nominal prices) 90
Table 49: Western Europe other OTC healthcare products value, 2003?08 ($m, nominal prices) 92
Table 50: Western Europe other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 93
Table 51: Western Europe other OTC healthcare products company share (top 20 companies) by value, 2007?08 (%) 95
Table 52: Western Europe other OTC healthcare products value, by company, 2007?08 ($m, nominal prices) 96
Table 53: Western Europe other OTC healthcare products distribution channels, by value, 2007?08 (%) 98
Table 54: Western Europe other OTC healthcare products value, by distribution channel, 2007?08 ($m, nominal prices) 98
Table 55: Western Europe plasters & bandages value, 2003?08 ($m, nominal prices) 100
Table 56: Western Europe plasters & bandages value forecast, 2008?13 ($m, nominal prices) 101
Table 57: Western Europe plasters & bandages company share (top 20 companies) by value, 2007?08 (%) 103
Table 58: Western Europe plasters & bandages value, by company, 2007?08 ($m, nominal prices) 104
Table 59: Western Europe plasters & bandages distribution channels, by value, 2007?08 (%) 106
Table 60: Western Europe plasters & bandages value, by distribution channel, 2007?08 ($m, nominal prices) 106
Table 61: Western Europe traditional medicines value, 2003?08 ($m, nominal prices) 108
Table 62: Western Europe traditional medicines value forecast, 2008?13 ($m, nominal prices) 109
Table 63: Western Europe traditional medicines company share (top 20 companies) by value, 2007?08 (%) 110
Table 64: Western Europe traditional medicines value, by company, 2007?08 ($m, nominal prices) 111
Table 65: Western Europe traditional medicines distribution channels, by value, 2007?08 (%) 113
Table 66: Western Europe traditional medicines value, by distribution channel, 2007?08 ($m, nominal prices) 113
Table 67: Western Europe vitamins and minerals value, 2003?08 ($m, nominal prices) 115
Table 68: Western Europe vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 116
Table 69: Western Europe vitamins and minerals company share (top 20 companies) by value, 2007?08 (%) 118
Table 70: Western Europe vitamins and minerals value, by company, 2007?08 ($m, nominal prices) 119
Table 71: Western Europe vitamins and minerals distribution channels, by value, 2007?08 (%) 121
Table 72: Western Europe vitamins and minerals value, by distribution channel, 2007?08 ($m, nominal prices) 121


[Inhaltsverzeichnis ausblenden]